Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-AUST: The Spot sign and Tranexamic acid On Preventing ICH growth – AUStralasia Trial
2013-001262-42Phase 2Completed
- Sponsor
- National Stroke Research Institute
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in intracerebral hemorrhage (ICH) comparing Tranexamic acid with Placebo (2 arms). Started Oct 2013; status: completed.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2013-001262-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001262-42.